BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND CSF3R, CD114, 1441, ENSG00000119535, GCSFR AND Prognosis
5 results:

  • 1. HiFreSP: A novel high-frequency sub-pathway mining approach to identify robust prognostic gene signatures.
    Li M; Zhao J; Li X; Chen Y; Feng C; Qian F; Liu Y; Zhang J; He J; Ai B; Ning Z; Liu W; Bai X; Han X; Wu Z; Xu X; Tang Z; Pan Q; Xu L; Li C; Wang Q; Li E
    Brief Bioinform; 2020 Jul; 21(4):1411-1424. PubMed ID: 31350847
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative breast cancer.
    Yang R; Xing L; Wang M; Chi H; Zhang L; Chen J
    Cell Physiol Biochem; 2018; 50(2):473-488. PubMed ID: 30308479
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The prognostic significance of Cdc6 and Cdt1 in breast cancer.
    Mahadevappa R; Neves H; Yuen SM; Bai Y; McCrudden CM; Yuen HF; Wen Q; Zhang SD; Kwok HF
    Sci Rep; 2017 Apr; 7(1):985. PubMed ID: 28428557
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Nestin: predicting specific survival factors for breast cancer.
    Gao N; Xu H; Liu C; Xu H; Chen G; Wang X; Li Y; Wang Y
    Tumour Biol; 2014 Mar; 35(3):1751-5. PubMed ID: 24443256
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Hypoxia-induced dedifferentiation of tumor cells--a mechanism behind heterogeneity and aggressiveness of solid tumors.
    Axelson H; Fredlund E; Ovenberger M; Landberg G; PĂ„hlman S
    Semin Cell Dev Biol; 2005; 16(4-5):554-63. PubMed ID: 16144692
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.